Quick Takeaways
- Matthew Angel filed SCHEDULE 13D/A for TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST).
- Disclosed ownership: 37%.
- Date of event: 24 Mar 2026.
Matthew Angel - 24 Mar 2026 SCHEDULE 13D/A Report for TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST)
- Filing Manager
- Matthew Angel
- Reporting Manager
- Matthew Angel
- Symbol
- TPST
- Shares outstanding
- 14,790,150 shares
- Disclosed Ownership
- 5,531,516 shares
- Ownership
- 37%
- Form type
- SCHEDULE 13D/A
- Filing time
- 25 Mar 2026, 17:33:43 UTC
- Date of event
- 24 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Matthew Angel disclosed 37% ownership in TEMPEST THERAPEUTICS, INC. Common Stock, par value $0.001 per share (TPST) on 24 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Mar 2026, 17:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Matthew Angel | 37% | 5,531,516 | 5,531,516 | 0 | /s/ Matthew Angel | Matthew Angel | 0001931356 |